Aggressive focus by DOJ has put increased burden on stakeholders to understand their obligations and exposure.
Anthony J. Mahajan
Advertisement
Chair of Frier Levitt’s White Collar Defense and Government Investigations practice
Articles by Anthony J. Mahajan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
3
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5